Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Baroreflex | 19 | 2010 | 154 | 3.100 |
Why?
|
| Vagus Nerve | 13 | 2010 | 459 | 2.090 |
Why?
|
| Sympathetic Nervous System | 15 | 2010 | 521 | 1.580 |
Why?
|
| Heart Rate | 30 | 2012 | 4214 | 1.220 |
Why?
|
| Blood Pressure | 35 | 2014 | 8543 | 1.140 |
Why?
|
| Atropine | 6 | 2010 | 244 | 1.130 |
Why?
|
| Carotid Arteries | 7 | 2010 | 942 | 0.920 |
Why?
|
| Autonomic Nervous System | 7 | 2017 | 707 | 0.870 |
Why?
|
| Lower Body Negative Pressure | 5 | 2014 | 23 | 0.830 |
Why?
|
| Spinal Cord Injuries | 3 | 2017 | 928 | 0.820 |
Why?
|
| Cerebrovascular Circulation | 4 | 2014 | 2725 | 0.710 |
Why?
|
| Heart | 10 | 2010 | 4446 | 0.640 |
Why?
|
| Aging | 13 | 2010 | 8744 | 0.610 |
Why?
|
| Autonomic Dysreflexia | 1 | 2017 | 9 | 0.590 |
Why?
|
| Electric Stimulation Therapy | 2 | 2014 | 635 | 0.550 |
Why?
|
| Arrhythmia, Sinus | 5 | 2010 | 48 | 0.520 |
Why?
|
| Muscarinic Antagonists | 3 | 2012 | 136 | 0.510 |
Why?
|
| Parasympatholytics | 4 | 2010 | 89 | 0.500 |
Why?
|
| Forearm | 3 | 2012 | 427 | 0.500 |
Why?
|
| Physical Fitness | 3 | 2009 | 744 | 0.470 |
Why?
|
| Cardiovascular Physiological Phenomena | 6 | 2006 | 241 | 0.460 |
Why?
|
| Exercise | 9 | 2014 | 5955 | 0.450 |
Why?
|
| Respiration | 12 | 2001 | 1665 | 0.420 |
Why?
|
| Glycopyrrolate | 1 | 2012 | 35 | 0.420 |
Why?
|
| Cholinergic Fibers | 1 | 2012 | 69 | 0.410 |
Why?
|
| Arteries | 2 | 2009 | 1127 | 0.410 |
Why?
|
| Blood Circulation | 3 | 2006 | 248 | 0.370 |
Why?
|
| Middle Cerebral Artery | 1 | 2012 | 271 | 0.370 |
Why?
|
| Physical Exertion | 9 | 1996 | 668 | 0.370 |
Why?
|
| Leg | 4 | 2011 | 1088 | 0.360 |
Why?
|
| Thoracic Vertebrae | 1 | 2014 | 613 | 0.330 |
Why?
|
| Spinal Cord | 1 | 2017 | 1811 | 0.320 |
Why?
|
| Fractals | 1 | 2009 | 127 | 0.310 |
Why?
|
| Arm | 2 | 2011 | 591 | 0.310 |
Why?
|
| Vascular Resistance | 6 | 2001 | 939 | 0.300 |
Why?
|
| Oxygen Consumption | 5 | 2011 | 1880 | 0.300 |
Why?
|
| Models, Cardiovascular | 3 | 2007 | 981 | 0.300 |
Why?
|
| Exercise Therapy | 2 | 2014 | 939 | 0.290 |
Why?
|
| Pressoreceptors | 4 | 2010 | 99 | 0.260 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 721 | 0.250 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2009 | 775 | 0.250 |
Why?
|
| Biological Clocks | 2 | 2004 | 321 | 0.230 |
Why?
|
| Supine Position | 6 | 2009 | 208 | 0.200 |
Why?
|
| Photoplethysmography | 1 | 2001 | 66 | 0.180 |
Why?
|
| Electrocardiography | 10 | 2009 | 6412 | 0.180 |
Why?
|
| Pulmonary Ventilation | 2 | 2014 | 375 | 0.180 |
Why?
|
| Homeostasis | 5 | 2014 | 3348 | 0.180 |
Why?
|
| Reaction Time | 1 | 2007 | 2101 | 0.180 |
Why?
|
| Blood Volume | 3 | 2002 | 545 | 0.180 |
Why?
|
| Reflex | 1 | 2002 | 375 | 0.170 |
Why?
|
| Stress, Psychological | 2 | 2008 | 4530 | 0.170 |
Why?
|
| Isometric Contraction | 2 | 1991 | 149 | 0.170 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2012 | 277 | 0.170 |
Why?
|
| Adrenal Glands | 2 | 1992 | 557 | 0.160 |
Why?
|
| Adult | 44 | 2014 | 223646 | 0.160 |
Why?
|
| Physical Endurance | 2 | 2001 | 369 | 0.160 |
Why?
|
| Male | 48 | 2014 | 364719 | 0.140 |
Why?
|
| Hemodynamics | 10 | 2010 | 4194 | 0.140 |
Why?
|
| Nitroprusside | 4 | 2007 | 272 | 0.140 |
Why?
|
| Regional Blood Flow | 5 | 2012 | 1500 | 0.130 |
Why?
|
| Tilt-Table Test | 2 | 2009 | 80 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2001 | 1110 | 0.120 |
Why?
|
| Phenylephrine | 3 | 2007 | 292 | 0.120 |
Why?
|
| Muscles | 3 | 1991 | 1582 | 0.120 |
Why?
|
| Fourier Analysis | 3 | 2008 | 439 | 0.120 |
Why?
|
| Models, Biological | 2 | 2010 | 9495 | 0.120 |
Why?
|
| Anaerobic Threshold | 1 | 2014 | 52 | 0.120 |
Why?
|
| Analysis of Variance | 5 | 2008 | 6229 | 0.120 |
Why?
|
| Humans | 56 | 2017 | 768166 | 0.110 |
Why?
|
| Sex Characteristics | 2 | 2010 | 2650 | 0.110 |
Why?
|
| Linear Models | 4 | 2010 | 5884 | 0.110 |
Why?
|
| Posture | 4 | 1996 | 957 | 0.110 |
Why?
|
| Adrenergic beta-Antagonists | 4 | 2009 | 1243 | 0.110 |
Why?
|
| Tidal Volume | 5 | 2001 | 518 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10760 | 0.110 |
Why?
|
| Female | 32 | 2014 | 397192 | 0.100 |
Why?
|
| Atenolol | 3 | 2009 | 99 | 0.100 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1996 | 881 | 0.100 |
Why?
|
| Coronary Artery Disease | 2 | 2010 | 6568 | 0.100 |
Why?
|
| Adaptation, Physiological | 2 | 2009 | 1312 | 0.090 |
Why?
|
| Diastole | 2 | 2010 | 785 | 0.090 |
Why?
|
| Pulmonary Gas Exchange | 2 | 2011 | 389 | 0.090 |
Why?
|
| Young Adult | 6 | 2014 | 60066 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 1992 | 592 | 0.080 |
Why?
|
| Perfusion | 1 | 2014 | 1401 | 0.080 |
Why?
|
| Exercise Test | 3 | 2011 | 2186 | 0.080 |
Why?
|
| Middle Aged | 18 | 2014 | 223492 | 0.080 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 2009 | 170 | 0.080 |
Why?
|
| Weightlessness | 1 | 2010 | 103 | 0.080 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1375 | 0.080 |
Why?
|
| Mathematical Concepts | 1 | 2008 | 75 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 1995 | 1110 | 0.080 |
Why?
|
| Elasticity | 2 | 2008 | 656 | 0.080 |
Why?
|
| Oscillometry | 2 | 1998 | 151 | 0.070 |
Why?
|
| Reference Values | 5 | 2002 | 4938 | 0.070 |
Why?
|
| Aged | 15 | 2010 | 171504 | 0.070 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 1377 | 0.070 |
Why?
|
| Health | 1 | 2010 | 398 | 0.070 |
Why?
|
| Space Flight | 1 | 2010 | 219 | 0.070 |
Why?
|
| Hyperemia | 1 | 1988 | 224 | 0.070 |
Why?
|
| Motion | 1 | 2010 | 790 | 0.070 |
Why?
|
| Electrophysiology | 1 | 2009 | 1266 | 0.060 |
Why?
|
| Mathematics | 1 | 2006 | 704 | 0.060 |
Why?
|
| Vasodilator Agents | 2 | 2007 | 990 | 0.060 |
Why?
|
| Head-Down Tilt | 2 | 2010 | 67 | 0.060 |
Why?
|
| Peroneal Nerve | 2 | 2001 | 80 | 0.060 |
Why?
|
| Movement | 1 | 2011 | 1490 | 0.060 |
Why?
|
| Patient Compliance | 1 | 2014 | 2697 | 0.060 |
Why?
|
| Speech | 1 | 2008 | 557 | 0.060 |
Why?
|
| Cardiac Output | 4 | 2002 | 838 | 0.060 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 656 | 0.050 |
Why?
|
| Muscle Contraction | 1 | 1988 | 1209 | 0.050 |
Why?
|
| Ultrasonography | 3 | 2008 | 6004 | 0.050 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 8542 | 0.050 |
Why?
|
| Hand | 1 | 1988 | 913 | 0.050 |
Why?
|
| Catecholamines | 2 | 1992 | 389 | 0.050 |
Why?
|
| Sinoatrial Node | 1 | 2001 | 99 | 0.050 |
Why?
|
| Vasomotor System | 1 | 2001 | 208 | 0.040 |
Why?
|
| Models, Neurological | 1 | 2009 | 1776 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2010 | 6340 | 0.040 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2002 | 217 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2001 | 304 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 2709 | 0.040 |
Why?
|
| Neural Conduction | 1 | 2001 | 443 | 0.040 |
Why?
|
| Body Composition | 1 | 2009 | 2462 | 0.040 |
Why?
|
| Reproducibility of Results | 4 | 2001 | 20227 | 0.040 |
Why?
|
| Carbon Dioxide | 2 | 2001 | 1148 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 14783 | 0.040 |
Why?
|
| Artifacts | 2 | 2009 | 1926 | 0.040 |
Why?
|
| Rest | 2 | 1992 | 948 | 0.040 |
Why?
|
| Sick Sinus Syndrome | 1 | 1996 | 51 | 0.030 |
Why?
|
| Methods | 1 | 1997 | 1066 | 0.030 |
Why?
|
| Carotid Artery, Common | 1 | 1997 | 174 | 0.030 |
Why?
|
| Cardiovascular System | 4 | 1993 | 841 | 0.030 |
Why?
|
| Heart Block | 1 | 1996 | 390 | 0.030 |
Why?
|
| Sex Factors | 1 | 2009 | 10632 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 1209 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2010 | 59629 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2001 | 1489 | 0.030 |
Why?
|
| Stroke Volume | 4 | 2002 | 5622 | 0.030 |
Why?
|
| Norepinephrine | 2 | 1996 | 898 | 0.030 |
Why?
|
| Venous Pressure | 1 | 1992 | 55 | 0.030 |
Why?
|
| Time Factors | 3 | 2012 | 40218 | 0.030 |
Why?
|
| Animals | 4 | 2010 | 169246 | 0.030 |
Why?
|
| Epinephrine | 2 | 1996 | 794 | 0.020 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 1998 | 1515 | 0.020 |
Why?
|
| Postmenopause | 2 | 2001 | 2518 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 22291 | 0.020 |
Why?
|
| Blood Pressure Monitors | 1 | 1989 | 33 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2010 | 214 | 0.020 |
Why?
|
| Plethysmography | 1 | 1989 | 172 | 0.020 |
Why?
|
| Systole | 1 | 1991 | 937 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2010 | 260 | 0.020 |
Why?
|
| Body Temperature | 2 | 1989 | 780 | 0.020 |
Why?
|
| Astronauts | 1 | 2010 | 94 | 0.020 |
Why?
|
| Cold Temperature | 1 | 1992 | 791 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2009 | 272 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2010 | 704 | 0.020 |
Why?
|
| Skin | 2 | 1991 | 4503 | 0.020 |
Why?
|
| Hypotension, Orthostatic | 1 | 2010 | 258 | 0.020 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1987 | 243 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2001 | 5919 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2010 | 1134 | 0.020 |
Why?
|
| Algorithms | 2 | 2009 | 14164 | 0.020 |
Why?
|
| Body Temperature Regulation | 1 | 1987 | 292 | 0.020 |
Why?
|
| Prognosis | 1 | 2006 | 30010 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 1643 | 0.010 |
Why?
|
| Societies, Medical | 1 | 1997 | 3968 | 0.010 |
Why?
|
| Adiponectin | 1 | 2010 | 1117 | 0.010 |
Why?
|
| Electromyography | 1 | 1988 | 1401 | 0.010 |
Why?
|
| Leptin | 1 | 2010 | 1599 | 0.010 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2010 | 984 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1996 | 4978 | 0.010 |
Why?
|
| Adolescent | 2 | 2001 | 89169 | 0.010 |
Why?
|
| ROC Curve | 1 | 2009 | 3628 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2009 | 2359 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15662 | 0.010 |
Why?
|
| Hematocrit | 1 | 2002 | 623 | 0.010 |
Why?
|
| Airway Resistance | 1 | 2001 | 407 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 9015 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2009 | 6283 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4352 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2010 | 3858 | 0.010 |
Why?
|
| Progesterone | 1 | 2001 | 752 | 0.010 |
Why?
|
| Periodicity | 1 | 1998 | 348 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2001 | 2230 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2001 | 1695 | 0.010 |
Why?
|
| Propranolol | 2 | 1987 | 493 | 0.010 |
Why?
|
| Fatigue | 1 | 2002 | 1557 | 0.010 |
Why?
|
| Estrogens | 1 | 2001 | 1536 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7064 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4860 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 4030 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 23760 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2010 | 13053 | 0.010 |
Why?
|
| Running | 1 | 1996 | 490 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1996 | 1009 | 0.010 |
Why?
|
| Hypertension | 1 | 2010 | 8616 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1993 | 1741 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1995 | 36743 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 15948 | 0.000 |
Why?
|
| Placebos | 1 | 1987 | 1667 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1987 | 1441 | 0.000 |
Why?
|
| Oxygen | 1 | 1987 | 4270 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1988 | 12465 | 0.000 |
Why?
|
Concepts
(205)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_